Identification of Stem Cells in Myeloid Malignancies - Opportunities for Discovery and Translation
In this webinar, Dr. Christopher Y. Park, NYU School of Medicine discusses the conceptual and experimental principles of leukemic stem cell isolation. He gives an overview on the use of human primary cells for in vitro assays and the generation of xenograft models of myeloid malignancies, and provides novel insights derived from the study of purified disease stem cells in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Publish Date:
April 19, 2018
Related Multimedia
-
Drug Screening and Phenotypic Analysis in a Microwell-based 3D Cell Culture System
Publish Date: March 22, 2019 -
New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells
Publish Date: March 09, 2015 -
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
Humanized Mouse Models for Hematopoietic Stem Cell Research: Principles and Pitfalls
Publish Date: March 09, 2018
Explore Our Products
-
Diseased Human Peripheral Blood Products, Chronic Lymphocytic Leukemia (CLL)
Primary human cells, frozen -
Diseased Human Peripheral Blood Products, Hematological Cancer
Primary human cells, frozen -
Mobilized Human Peripheral Blood CD34+ Cells, Frozen
Primary human cells, frozen -
Diseased Human Peripheral Blood Products, Kidney Cancer
Primary human cells, fresh or frozen
